Victory Capital Management Inc Ikena Oncology, Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022
SELL
$5.61 - $13.85 $630,171 - $1.56 Million
-112,330 Closed
0 $0
Q4 2021

Feb 07, 2022
BUY
$10.52 - $16.96 $218,710 - $352,598
20,790 Added 22.71%
112,330 $1.41 Million
Q3 2021

Nov 02, 2021
SELL
$9.82 - $15.23 $6,284 - $9,747
-640 Reduced 0.69%
91,540 $1.16 Million
Q1 2021

May 04, 2021
BUY
$25.6 - $32.0 $2.36 Million - $2.95 Million
92,180 New
92,180 $2.6 Million

Others Institutions Holding IKNA

# of Institutions
60
Shares Held
30.4M
Call Options Held
0
Put Options Held
0
View Full List

About Ikena Oncology, Inc.

IKNA Quotes by TradingView
  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $51.8M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email